News - Pharmaceutical, Spectrum Pharmaceuticals

Filter

Popular Filters

Bladder cancer market to witness moderate growth by 2017, despite anticipated launch of EOoquin

Bladder cancer market to witness moderate growth by 2017, despite anticipated launch of EOoquin

22-01-2014

The bladder cancer therapeutics market in the six major countries is forecast to climb from $239.3 million…

EOquinEuropeMarkets & MarketingOncologyPharmaceuticalSpectrum PharmaceuticalsUSA

Ligand to earn up to $50 million in deal with Spectrum for Captisol-enabled melphalan

14-03-2013

Ligand Pharmaceuticals (Nasdaq: LGND) has signed a global license and supply agreements with fellow US…

FinancialLicensingLigand PharmaceuticalsmelphalanOncologyPharmaceuticalSpectrum Pharmaceuticals

Global epigenetic therapies market to increase at a CAGR of 10% through 2017

04-03-2013

The global epigenetic therapies market is expected to reach a total value of around $2.518 billion by…

belinostatBiotechnologyCelgeneFaridakGlobalMarkets & MarketingNovartisOncologypanobinostatPharmaceuticalSpectrum PharmaceuticalsTopotargetVidaza

Topotarget says belinostat pivotal trial meets primary endpoint

26-09-2012

Denmark's Topotarget (Nasdaq OMX: TOPO) said that the primary endpoint has been met for the pivotal trial…

belinostatOncologyPharmaceuticalResearchSpectrum PharmaceuticalsTopotarget

Spectrum plunges on negative trial results; makes bid for Allos

10-04-2012

US biotech firm Spectrum Pharmaceuticals (Nasdaq: SPPI) saw its shares plunge as much as 14%, before…

Allos TherapeuticsapaziquoneBiotechnologyFolotynMergers & AcquisitionsOncologyPharmaceuticalResearchSpectrum Pharmaceuticals

Spectrum in-licenses novel GCSF drug from Hanmi Pharma

01-02-2012

USA-based Spectrum Pharmaceuticals (NasdaqGS: SPPI) has entered into a co-development and commercialization…

Hanmi PharmaceuticalLicensingOncologyPharmaceuticalSpectrum Pharmaceuticals

Spectrum Pharma to acquire non-US rights to market Zevalin

26-01-2012

USA-based Spectrum Pharmaceuticals (NasdaqGS: SPPI) says it has entered into an agreement to acquire…

BayerMergers & AcquisitionsOncologyPharmaceuticalSpectrum PharmaceuticalsZevalin

Back to top